Skip to content

OraSure Technologies OSUR Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Revvity logo
RevvityRVTY
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
Illumina logo
IlluminaILMN
CareDx logo
CareDxCDNA

Other financials

Income statement

See full
Revenue$27.9M-6.7%
Gross profit$11.8M-4.0%
Operating income-$23.3M-31.1%
Net income-$22.4M-39.5%
EPS (diluted)-$0.32-52.4%

Balance sheet

See full
Cash & equivalents$177.0M-28.5%
Total debt$12.7M-10.9%
Total equity$313.3M-20.9%
Total assets$379.2M-17.1%

Cash flow

See full
Operating cash flow-$13.9M+29.6%
CapEx$913.0K+117%
Free cash flow-$14.8M+26.5%

Valuation

See full
Market cap$303.62M+35.3%
Enterprise value$139.32M-1,654%
P/S2.7×+1.3×

Profitability

See full
Gross margin42.2%+0.4pp
Operating margin-68.6%-149pp
Net margin-66.4%-115pp
FCF margin-42.4%-43.3pp

Returns & leverage

See full
Return on equity-21.2%-50.4pp
Debt / equity0.0×
Current ratio5.5×-6.9×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: OraSure Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OraSure Technologies's contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OraSure Technologies's contingent consideration fair value adjustments?
OraSure Technologies (OSUR) reported contingent consideration fair value adjustments of $93K in Q1 2026.
How has OraSure Technologies's contingent consideration fair value adjustments changed year-over-year?
OraSure Technologies's contingent consideration fair value adjustments decreased by 80.5% year-over-year, from $478K to $93K.
What is the long-term trend for OraSure Technologies's contingent consideration fair value adjustments?
Over 4 years (2021 to 2025), OraSure Technologies's contingent consideration fair value adjustments has grown at a 31.5% compound annual growth rate (CAGR), from -$1.53M to $4.57M.